Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

J&J/Cordis Teramed Alliance Suggests Swifter Access To $1 Bil. AAA Market

This article was originally published in The Gray Sheet

Executive Summary

Johnson & Johnson/Cordis will join a crowded field of players in the worldwide abdominal aortic aneurysm (AAA) market, expected to top $1 bil. by 2008, following the acquisition of privately-held Teramed

You may also be interested in...



Cordis Stresses Durability Of Fortron AAA System, European Safety Results

The positive safety profile of Johnson & Johnson/ Cordis' Fortron abdominal aortic aneurysm (AAA) stent graft, as demonstrated in Europe, likely will be a key component of the firm's U.S. marketing strategy

Cordis Stresses Durability Of Fortron AAA System, European Safety Results

The positive safety profile of Johnson & Johnson/ Cordis' Fortron abdominal aortic aneurysm (AAA) stent graft, as demonstrated in Europe, likely will be a key component of the firm's U.S. marketing strategy

Cook Zenith AAA Endovascular Graft PMA Pending At FDA

Cook is expecting its Zenith abdominal aortic aneurysm endovascular stent-graft to go before FDA's Circulatory System Devices Panel this fall

Related Content

UsernamePublicRestriction

Register

MT015874

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel